| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Across the last three months, Ocular Therapeutix, Inc.'s insiders have reduced their positions by a net 63,819 shares worth roughly $568K. In the past 30 days, 0 insiders bought and 3 sold. The bias lately has been to the sell side.
Not all activity pointed one way: 3 insiders sold in the same window, though all of them still hold shares. Classified under Biotechnology (Health Care sector), OCUL's insider flows are most useful compared with peers in the same group.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Other | 416.0K | - | - | |
| COO | 366.5K | $3.75M | - | |
| Other | 326.9K | $3.52M | - | |
| Other | 307.5K | $2.17M | -10,869 | |
| Other | 300.1K | $2.48M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb 12, 2026 | Waheed Nadia | Chief Medical Officer | Sell | 7,863 | $9.04 | $71,081.52 | -2.4% | - | - | |
| Feb 12, 2026 | Notman Donald | Chief Operating Officer | Sell | 11,446 | $9.04 | $103,471.84 | -3.0% | - | - | |
| Feb 12, 2026 | Dugel Pravin | See Remarks | Sell | 124,882 | $9.04 | $1,128,933.28 | -4.0% | - | - | |
| Feb 4, 2026 | Notman Donald | Chief Operating Officer | Sell | 11,490 | $8.82 | $101,397.60 | -3.0% | - | - | |
| Nov 24, 2025 | Nayak Sanjay | Chief Strategy Officer | Sell | 1,878 | $12.04 | $22,611.12 | -0.7% | -30.4% | - | |
| Nov 24, 2025 | Dugel Pravin | See Remarks | Sell | 19,530 | $12.04 | $235,141.20 | -0.6% | -30.4% | - | |
| Nov 24, 2025 | Kaiser Peter | Chief Development Officer | Sell | 3,007 | $12.02 | $36,144.14 | -1.5% | -30.4% | - | |
| Nov 24, 2025 | Heier Jeffrey S.61 | Chief Scientific Officer | Sell | 3,469 | $12.04 | $41,766.76 | -1.4% | -30.4% | - | |
| Nov 5, 2025 | Saroj Namrata | Chief Business Officer | Sell | 25,865 | $10.74 | $277,790.10 | -12.9% | -21.3% | - | |
| Oct 8, 2025 | Anderman Todd | Chief Legal Officer | Sell | 11,132 | $12.34 | $137,368.88 | -11.3% | -5.5% | - |